FdaApplication
NDA 215029
Identifiers
- fda_app_no: NDA215029
Properties
| Property | Value |
|---|---|
| applicant_name | MEDRX USA INC |
| application_type | NDA |
| approval_date | 2025-09-24 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BONDLIDO | LIDOCAINE | 10% | SYSTEM;TOPICAL |
1 product